The estimated Net Worth of Capital Management Lp Regal... is at least $3.46 Million dollars as of 6 June 2014. Capital Regal owns over 2,252 units of Oramed Pharmaceuticals, Inc stock worth over $3,459,656 and over the last 12 years Capital sold ORMP stock worth over $0.
Capital has made over 4 trades of the Oramed Pharmaceuticals, Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Capital bought 2,252 units of ORMP stock worth $9,999 on 6 June 2014.
The largest trade Capital's ever made was buying 75,000 units of Oramed Pharmaceuticals, Inc stock on 24 March 2014 worth over $796,500. On average, Capital trades about 19,311 units every 50 days since 2012. As of 6 June 2014 Capital still owns at least 1,453,637 units of Oramed Pharmaceuticals, Inc stock.
You can see the complete history of Capital Regal stock trades at the bottom of the page.
Over the last 17 years, insiders at Oramed Pharmaceuticals, Inc have traded over $7,377,390 worth of Oramed Pharmaceuticals, Inc stock and bought 881,642 units worth $3,583,418 . The most active insiders traders include Miriam Kidron, Leonard Sank, and Nadav Kidron. On average, Oramed Pharmaceuticals, Inc executives and independent directors trade stock every 111 days with the average trade being worth of $97,149. The most recent stock trade was executed by Arie Mayer on 3 April 2023, trading 8,809 units of ORMP stock currently worth $19,556.
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
Oramed Pharmaceuticals, Inc executives and other stock owners filed with the SEC include: